Call for overhaul of drug industry business model

Call for overhaul of drug industry business model

LONDON (Reuters) – Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.